Massivemarkets

SEC Form 4

Scribe Therapeutics Inc. (SCTX) insider trading

In the 12 months to Nov 19, 2026, 6 SCTX insiders reported open-market purchases of $71.3M across 6 filings; no open-market sales were filed.

Latest filing · Last 12 months · Source: SEC EDGAR · How we count

Open-market sales
$0
0 filings · 0 insiders
Open-market purchases
$71.3M
6 filings

Who traded SCTX, and when

  • Purchase

SCTX daily close from Jul 24, 2026 to Nov 18, 2026, between $14.05 and $37.25, last $14.05. 0 sale and 6 purchase filings by 6 insiders, marked at their filing dates. Behzad Aghazadeh, Director: bought $36.3M across 1 filing, first filed Jul 28, 2026, last Jul 28, 2026. Carl L. Gordon, Director: bought $15.0M across 1 filing, first filed Jul 29, 2026, last Jul 29, 2026. OrbiMed Capital GP VIII LLC, Director: bought $15.0M across 1 filing, first filed Jul 29, 2026, last Jul 29, 2026. Benjamin A. Horowitz, 10% owner: bought $5.0M across 1 filing, first filed Jul 29, 2026, last Jul 29, 2026. Svetlana Lucas, Chief Business Officer: bought $45.0K across 1 filing, first filed Jul 27, 2026, last Jul 27, 2026. David Parrot, Chief Financial Officer: bought $40.0K across 1 filing, first filed Jul 27, 2026, last Jul 27, 2026.

Largest mark · tap a row for others

Behzad Aghazadeh · Director

Purchase $36,259,761

2,391,238 shares at $15.16 avg

Filed Jul 28, 2026 · traded Jul 24

Close on filing date $18.06

SCTX daily closelast $14.05

Behzad Aghazadeh · Director

$36.3M bought

Carl L. Gordon · Director

$15.0M bought

OrbiMed Capital GP VIII LLC · Director

$15.0M bought

Benjamin A. Horowitz · 10% owner

$5.0M bought

Svetlana Lucas · Chief Business Officer

$45.0K bought

David Parrot · Chief Financial Officer

$40.0K bought
One row per insider; marks sit at the SEC filing date, sized by dollar value.

Open-market trades

6 filings in the last 12 months
Other insider activity (not market trades) · 5 records
  • Other5 records

Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.

How to read this page

Open-market purchase or sale
A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
Filing date
Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Counted once
When several owners (a fund and its partners, say) report the same trade, it's counted once. Corrected filings replace the originals.

Frequently asked questions

Has Scribe Therapeutics Inc.'s CEO sold stock?

No. Benjamin L. Oakes (CEO) made no open-market sales filed as CEO in the last 12 months.

How current is SCTX’s insider data?

These are SCTX Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.

What counts as an open-market buy or sell?

Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.

Build with AI

Track SCTX insider trades with your agent

This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:

Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for SCTX every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.

Live market data from the Massive API and MCP.Get a free API key

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.